Skip to main content
SpringerLink
Log in

BRCA testing in early breast cancer cost effective in Malaysia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 US dollars

  2. low- or middle-income country

Reference

  • Lim KK, et al. Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia. Applied Health Economics and Health Policy : 23 Mar 2018. Available from: URL: http://doi.org/10.1007/s40258-018-0384-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

BRCA testing in early breast cancer cost effective in Malaysia. PharmacoEcon Outcomes News 800, 14 (2018). https://doi.org/10.1007/s40274-018-4833-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4833-2

Search

Navigation